After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out about its atopic dermatitis treatment Ebglyss. Ebglyss is a once-monthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback